Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,067 | 2,122 | N/A | N/A | N/A |
| Income taxes - deferred | -2 | 2 | N/A | N/A | N/A |
| Other Working Capital | 2,461 | 273 | N/A | N/A | N/A |
| Other Operating Activity | -2,817 | -3,635 | 0 | 0 | 0 |
| Operating Cash Flow | $-1,425 | $-1,238 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -566 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 12,420 | 839 | 0 | 0 | 0 |
| Investing Cash Flow | $11,853 | $839 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 566 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -11,584 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -9 | -32 | 0 | 0 | 0 |
| Financing Cash Flow | $-11,026 | $-32 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,658 | 2,090 | N/A | N/A | N/A |
| End Cash Position | 1,061 | 1,658 | N/A | N/A | N/A |
| Net Cash Flow | $-597 | $-432 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,425 | -1,238 | N/A | N/A | N/A |
| Free Cash Flow | -1,425 | -1,238 | 0 | 0 | 0 |